These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 15016089

  • 21. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H, Calo' G, Albrecht E, Guerrini R, Bienert M.
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M, Mela F, Veronesi C, Guerrini R, Salvadori S, Federici M, Mercuri NB, Rizzi A, Franchi G, Beani L, Bianchi C, Morari M.
    J Neurosci; 2004 Jul 28; 24(30):6659-66. PubMed ID: 15282268
    [Abstract] [Full Text] [Related]

  • 24. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
    Kapusta DR, Burmeister MA, Calo' G, Guerrini R, Gottlieb HB, Kenigs VA.
    J Pharmacol Exp Ther; 2005 Aug 28; 314(2):643-51. PubMed ID: 15855356
    [Abstract] [Full Text] [Related]

  • 25. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS, Marti M, Morari M.
    Neuroscience; 2010 Mar 10; 166(1):40-8. PubMed ID: 20006677
    [Abstract] [Full Text] [Related]

  • 26. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
    Wright KE, McDonald J, Barnes TA, Rowbotham DJ, Guerrini R, Calo' G, Lambert DG.
    Neurosci Lett; 2003 Aug 07; 346(3):145-8. PubMed ID: 12853105
    [Abstract] [Full Text] [Related]

  • 27. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
    Nazzaro C, Rizzi A, Salvadori S, Guerrini R, Regoli D, Zeilhofer HU, Calo G.
    Peptides; 2007 Mar 07; 28(3):663-9. PubMed ID: 17161885
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY, Trapella C, Chiou LC.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):84-9. PubMed ID: 19374842
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux.
    D'Agostino B, Marrocco G, De Nardo M, Calò G, Guerrini R, Gallelli L, Advenier C, Rossi F.
    Br J Pharmacol; 2005 Mar 15; 144(6):813-20. PubMed ID: 15685213
    [Abstract] [Full Text] [Related]

  • 32. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G.
    Peptides; 2009 Feb 15; 30(2):248-55. PubMed ID: 18992780
    [Abstract] [Full Text] [Related]

  • 33. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
    Calo' G, Rizzi A, Cifani C, Micioni Di Bonaventura MV, Regoli D, Massi M, Salvadori S, Lambert DG, Guerrini R.
    CNS Neurosci Ther; 2011 Jun 15; 17(3):178-98. PubMed ID: 20497197
    [Abstract] [Full Text] [Related]

  • 34. Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.
    Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TC, Rae GA, Salvadori S, Regoli D, Calo' G.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun 15; 369(6):547-53. PubMed ID: 15197534
    [Abstract] [Full Text] [Related]

  • 35. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L, Di Cesare Mannelli L, Guerrini R, Trapella C, Zanardelli M, Ciccocioppo R, Rizzi A, Ghelardini C, Calò G.
    Eur J Pharmacol; 2015 May 05; 754():73-81. PubMed ID: 25704616
    [Abstract] [Full Text] [Related]

  • 36. Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs.
    Hashiba E, Hirota K, Kudo T, Calo' G, Guerrini R, Matsuki A.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr 05; 367(4):342-7. PubMed ID: 12690425
    [Abstract] [Full Text] [Related]

  • 37. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C, Naudin B, Do Rego JC, Costentin J.
    Life Sci; 2002 Nov 29; 72(2):163-71. PubMed ID: 12417250
    [Abstract] [Full Text] [Related]

  • 38. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
    Hashimoto Y, Calo' G, Guerrini R, Smith G, Lambert DG.
    Eur J Pharmacol; 2002 Aug 02; 449(1-2):17-22. PubMed ID: 12163101
    [Abstract] [Full Text] [Related]

  • 39. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
    Guerrini R, Carra' G, Calo' G, Trapella C, Marzola E, Rizzi D, Regoli D, Salvadori S.
    J Pept Res; 2004 Jun 02; 63(6):477-84. PubMed ID: 15175020
    [Abstract] [Full Text] [Related]

  • 40. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR, Glen T, Davies MR, Paterson SJ, Corbett AD.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):217-23. PubMed ID: 10607879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.